These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6246856)

  • 21. Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.
    Chany C; Cerutti I
    Arch Virol; 1977; 55(3):225-31. PubMed ID: 74245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of defective-interfering Semliki Forest virus on the histopathology of infection with virulent Semliki Forest virus in mice.
    Crouch CF; Mackenzie A; Dimmock NJ
    J Infect Dis; 1982 Sep; 146(3):411-6. PubMed ID: 6286798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interconversion of linear and circular forms of double-stranded RNA of encephalomyocarditis virus.
    Romanova LI; Agol VI
    Virology; 1979 Mar; 93(2):574-7. PubMed ID: 222058
    [No Abstract]   [Full Text] [Related]  

  • 24. The responses of nude-athymic mice to nominally avirulent togavirus infections.
    Bradish CJ; Fitzgeorge R; Titmuss D; Baskerville A
    J Gen Virol; 1979 Mar; 42(3):555-66. PubMed ID: 311822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence of a mouse-adapted Semliki Forest virus strain is associated with reduced susceptibility to interferon.
    Deuber SA; Pavlovic J
    J Gen Virol; 2007 Jul; 88(Pt 7):1952-1959. PubMed ID: 17554028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The early responses of mice to respiratory or intraperitoneal infection by defined virulent and avirulent strains of Semliki forest virus.
    Bradish CJ; Allner K
    J Gen Virol; 1972 Jun; 15(3):205-18. PubMed ID: 5040350
    [No Abstract]   [Full Text] [Related]  

  • 27. Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.
    Kraaijeveld CA; Benaissa-Trouw BJ; Harmsen M; Snippe H
    Arch Virol; 1986; 91(1-2):83-92. PubMed ID: 3489451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral profile of Nyctanthes arbortristis L. against encephalitis causing viruses.
    Gupta P; Bajpai SK; Chandra K; Singh KL; Tandon JS
    Indian J Exp Biol; 2005 Dec; 43(12):1156-60. PubMed ID: 16359127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.
    Stebbing N; Lindley IJ; Dawson KM
    Infect Immun; 1980 Sep; 29(3):960-5. PubMed ID: 6253403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of myocrisin and 1-asparaginase.
    Bradish CJ; Allner K; Fitzgeorge R
    J Gen Virol; 1975 Aug; 28(2):239-50. PubMed ID: 809543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.
    Werner GH; Jasmin C; Chermann JC
    J Gen Virol; 1976 Apr; 31(1):59-64. PubMed ID: 177729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice.
    Maheshwari RK; Srikantan V; Bhartiya D
    J Virol; 1991 Feb; 65(2):992-5. PubMed ID: 1846212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice.
    Géniteau-Legendre M; Forestier F; Quéro AM; German A
    Antiviral Res; 1987 Mar; 7(3):161-7. PubMed ID: 2440381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection patterns in mice of an avirulent and virulent strain of Semliki Forest virus.
    Pusztai R; Gould EA; Smith H
    Br J Exp Pathol; 1971 Dec; 52(6):669-77. PubMed ID: 5135538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amphotericin B and its methyl ester on the antiviral activity of polyinosinic:polycytidylic acid.
    Borden EC; McBain JA; Leonhardt PH
    Antimicrob Agents Chemother; 1979 Aug; 16(2):203-9. PubMed ID: 225986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
    Stringfellow DA; Kern ER; Kelsey DK; Glasgow LA
    J Infect Dis; 1977 Apr; 135(4):540-51. PubMed ID: 192804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of N-acetylethyleneimine [AEI] for the inactivation of Semliki Forest virus in vitro.
    Amor S; Webb HE
    J Med Virol; 1986 Aug; 19(4):367-76. PubMed ID: 3746260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A putative interferon induced in hamsters by poly(I) . poly(C).
    Round EM; Stebbing N
    J Interferon Res; 1981; 1(3):451-6. PubMed ID: 6180078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of different polyribonucleotides on the induction of antibodies to DNA and RNA and serum complement level in mice.
    Cebecauer L; Rovenský J; Doskocil J; Pekárek J; Borecký L; Zitńan D
    Acta Biol Med Ger; 1979; 38(5-6):843-6. PubMed ID: 525155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.